ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Effects of Dietary Proteins on Hepatic Lipid Metabolism

This study is currently recruiting participants.
Verified by University of Lausanne, June 2008

Sponsors and Collaborators: University of Lausanne
University Hospital Inselspital, Berne
Information provided by: University of Lausanne
ClinicalTrials.gov Identifier: NCT00558740
  Purpose

Individuals submitted to a high-fat or a high-fructose/sucrose diet develop, over a 6 day-period, several features of the metabolic syndrome, including increased plasma triglycerides, increased intrahepatic lipids, and decreased hepatic insulin sensitivity. It has been recently observed that the increase in intrahepatic lipids observed after a high fat diet is largely prevented when protein intake is concomitantly increased. This suggests that dietary protein protects the liver against some of the deleterious effects of a high fat diet. Mechanisms underlying this effect of protein may include an increased hepatic fat oxidation.

The aims of this study are:

  1. to evaluate the effects of dietary protein on several major pathways involved in hepatic lipid metabolism ( ketogenesis, lipid oxidation, de novo lipogenesis, VLDL-triglyceride secretion
  2. to determine whether the decrease in intra-hepatic lipids observed when dietary protein intake is increased are to be attributed to acute or long-term effects of proteins

Condition Intervention
Metabolic Syndrome X
Other: high protein intake

MedlinePlus related topics:   Dietary Proteins    Metabolic Syndrome   

ChemIDplus related topics:   Fructose    Lipids   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Other, Prospective
Official Title:   Effects of Dietary Proteins on Hepatic Lipid Metabolism

Further study details as provided by University of Lausanne:

Primary Outcome Measures:
  • Whole body lipid oxidation Medium chain triglyceride oxidation Long chain triglyceride oxidation VLDL-triglyceride kinetics Hepatic de novo lipogenesis whole body glucose and glycerol turnover [ Time Frame: acute effects of dietary proteins and after 4 days on a high protein day ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Energy expenditure Glucagon/insulin ratio Plasma growth hormone concentrations gene expression in subcutaneous adipose tissue Plasma ketone bodies concentrations [ Time Frame: acute effects of dietary proteins and after 4 days on a high protein day ] [ Designated as safety issue: No ]

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment:   22
Study Start Date:   May 2008
Estimated Study Completion Date:   December 2008

Groups/Cohorts Assigned Interventions
healthy volunteers Other: high protein intake
acute high protein intake chronic (6-day) high protein intake acute+chronic high protein intake control

Show detailed description  Show Detailed Description

  Eligibility
Ages Eligible for Study:   18 Years to 30 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample

Study Population

Healthy volunteers


Criteria

Inclusion Criteria:

  • age 18-30
  • sex male
  • BMI 19-25 kg/m2
  • sedentary
  • good physical health

Exclusion Criteria:

  • family history of diabetes
  • use of drugs or illicit substances
  • consumption of alcohol >50 g/week
  • vegetarians
  • smokers
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00558740

Contacts
Contact: Luc Tappy, MD     0041 21 692 55 41     luc.tappy@unil.ch    

Locations
Switzerland, Vaud
Centre Hospitalier Universitaire Vaudois     Recruiting
      Lausanne, Vaud, Switzerland, CH-1011
      Contact: Luc Tappy, MD     0041 21 692 55 41     luc.tappy@unil.ch    

Sponsors and Collaborators
University of Lausanne
University Hospital Inselspital, Berne

Investigators
Principal Investigator:     l Tappy, MD     University of Lausanne    
  More Information


Responsible Party:   Department of Physiology, University of Lausanne ( Prof. L uc Tappy )
Study ID Numbers:   protocol 66/07/CE/FBM, SNF 310000-109737
First Received:   November 14, 2007
Last Updated:   June 4, 2008
ClinicalTrials.gov Identifier:   NCT00558740
Health Authority:   Switzerland: Ethikkommision

Keywords provided by University of Lausanne:
Dietary protein  
Fructose  
VLDL-triglycerides  
Hepatic de novo lipogenesis  
Lipid oxidation  

Study placed in the following topic categories:
Hyperinsulinism
Metabolic Diseases
Metabolic Syndrome X
Syndrome X
Insulin Resistance
Metabolic disorder
Glucose Metabolism Disorders
Abdominal obesity metabolic syndrome

Additional relevant MeSH terms:
Pathologic Processes
Disease
Syndrome

ClinicalTrials.gov processed this record on October 07, 2008




Links to all studies - primarily for crawlers